92 related articles for article (PubMed ID: 8230373)
1. The relevance of positron emission tomography for the diagnosis and treatment of head and neck tumors.
Reisser C; Haberkorn U; Strauss LG
J Otolaryngol; 1993 Aug; 22(4):231-8. PubMed ID: 8230373
[TBL] [Abstract][Full Text] [Related]
2. PET monitoring of therapy response in head and neck squamous cell carcinoma.
Schöder H; Fury M; Lee N; Kraus D
J Nucl Med; 2009 May; 50 Suppl 1():74S-88S. PubMed ID: 19380408
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET and CT/MRI in oral cavity squamous cell carcinoma: a prospective study of 124 patients with histologic correlation.
Ng SH; Yen TC; Liao CT; Chang JT; Chan SC; Ko SF; Wang HM; Wong HF
J Nucl Med; 2005 Jul; 46(7):1136-43. PubMed ID: 16000282
[TBL] [Abstract][Full Text] [Related]
4. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
5. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
6. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
Tan A; Adelstein DJ; Rybicki LA; Saxton JP; Esclamado RM; Wood BG; Lorenz RR; Strome M; Carroll MA
Arch Otolaryngol Head Neck Surg; 2007 May; 133(5):435-40. PubMed ID: 17515501
[TBL] [Abstract][Full Text] [Related]
7. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
Basu D; Siegel BA; McDonald DJ; Nussenbaum B
Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620
[TBL] [Abstract][Full Text] [Related]
8. FDG-PET for prediction of tumour aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer.
Kitagawa Y; Sano K; Nishizawa S; Nakamura M; Ogasawara T; Sadato N; Yonekura Y
Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):63-71. PubMed ID: 12483411
[TBL] [Abstract][Full Text] [Related]
9. [Positron emission tomography (PET) in the evaluation of tumor proliferation and follow-up of therapy in ear, nose and throat tumors].
Haberkorn U; Strauss LG; Reisser C; van Kaick G
Radiologe; 1992 Jun; 32(6):296-301. PubMed ID: 1641487
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapeutic management of head and neck malignancies with positron emission tomography.
Reisser C; Haberkorn U; Dimitrakopoulou-Strauss A; Seifert E; Strauss LG
Arch Otolaryngol Head Neck Surg; 1995 Mar; 121(3):272-6. PubMed ID: 7873142
[TBL] [Abstract][Full Text] [Related]
11. Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy.
Haberkorn U; Strauss LG; Dimitrakopoulou A; Seiffert E; Oberdorfer F; Ziegler S; Reisser C; Doll J; Helus F; van Kaick G
J Nucl Med; 1993 Jan; 34(1):12-7. PubMed ID: 8418251
[TBL] [Abstract][Full Text] [Related]
12. In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck.
Minn H; Clavo AC; Grénman R; Wahl RL
J Nucl Med; 1995 Feb; 36(2):252-8. PubMed ID: 7830126
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation.
Greven KM; Williams DW; Keyes JW; McGuirt WF; Watson NE; Randall ME; Raben M; Geisinger KR; Cappellari JO
Cancer; 1994 Aug; 74(4):1355-9. PubMed ID: 8055460
[TBL] [Abstract][Full Text] [Related]
14. Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry.
Haberkorn U; Strauss LG; Reisser C; Haag D; Dimitrakopoulou A; Ziegler S; Oberdorfer F; Rudat V; van Kaick G
J Nucl Med; 1991 Aug; 32(8):1548-55. PubMed ID: 1869977
[TBL] [Abstract][Full Text] [Related]
15. [Fluorine-18]fluorodeoxyglucose positron emission tomography, DNA ploidy and growth fraction in squamous-cell carcinomas of the head and neck.
Jacob R; Welkoborsky HJ; Mann WJ; Jauch M; Amedee R
ORL J Otorhinolaryngol Relat Spec; 2001; 63(5):307-13. PubMed ID: 11528276
[TBL] [Abstract][Full Text] [Related]
16. [Evaluating the effectiveness of chemotherapy in patients with head-neck tumors using positron emission tomography (PET scan)].
Seifert E; Schadel A; Haberkorn U; Strauss LG
HNO; 1992 Mar; 40(3):90-3. PubMed ID: 1577631
[TBL] [Abstract][Full Text] [Related]
17. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas.
Laubenbacher C; Saumweber D; Wagner-Manslau C; Kau RJ; Herz M; Avril N; Ziegler S; Kruschke C; Arnold W; Schwaiger M
J Nucl Med; 1995 Oct; 36(10):1747-57. PubMed ID: 7562038
[TBL] [Abstract][Full Text] [Related]
18. Pilot study of positron emission tomography in patients with advanced head and neck cancer receiving radiotherapy and chemotherapy.
Berlangieri SU; Brizel DM; Scher RL; Schifter T; Hawk TC; Hamblen S; Coleman RE; Hoffman JM
Head Neck; 1994; 16(4):340-6. PubMed ID: 8056579
[TBL] [Abstract][Full Text] [Related]
19. FDG PET to evaluate combined intra-arterial chemotherapy and radiotherapy of head and neck neoplasms.
Kitagawa Y; Sadato N; Azuma H; Ogasawara T; Yoshida M; Ishii Y; Yonekura Y
J Nucl Med; 1999 Jul; 40(7):1132-7. PubMed ID: 10405132
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of response to radiotherapy with fluorine-18 deoxyglucose PET of head and neck squamous cell carcinomas.
Sakamoto H; Nakai Y; Ohashi Y; Matsuda M; Sakashita T; Nasako Y; Kitayama H; Kawabe J; Okamura T; Ochi H
Acta Otolaryngol Suppl; 1998; 538():254-60. PubMed ID: 9879431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
